RBC Capital Reiterates Outperform on Verastem, Maintains $13 Price Target

Benzinga · 10/18 13:51
RBC Capital analyst Gregory Renza reiterates Verastem (NASDAQ:VSTM) with a Outperform and maintains $13 price target.